AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22468094
Drug: tacrolimus, basiliximab,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tacrolimus, basiliximab, and mycophenolate mofetil with steroid withdrawal
Trial: 22468094
Drug: steroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: steroid treatment (control group)
Trial: 8295321
Drug: Lovastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (10 mg/d)
Trial: 23490655
Drug: CMF chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF chemotherapy (n=117)
Trial: 23490655
Drug: CMF chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF chemotherapy (per-protocol analysis)
Trial: 21185977
Drug: Nutrition education
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition education program (six weekly interactive lessons based on the Theory of Planned Behavior)
Trial: 21185977
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (six weekly nonrelated financial lessons by mail)
Trial: 17578321
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medicine and placebo
Trial: 15489577
Drug: Infliximab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (5 mg/kg) administered as three intravenous infusions
Trial: 15489577
Drug: High-dose prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose prednisolone (1.5 mg/kg daily for 2 weeks, followed by 1 mg/kg for 1 week, then weekly reduction of 5 mg)
Trial: 11597530
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg GTN patches
Trial: 8040999
Drug: Nebulised solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised solutions of saliva
Trial: 8040999
Drug: Nebulised solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised solutions of isotonic saline
Trial: 3141188
Drug: Percutaneous nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous nitroglycerin paste (10 mg)
Trial: 3141188
Drug: Nitroglycerin ointment
RxNorm normalized name: Nitroglycerin Ointment
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin ointment (5 mg)
Trial: 29110615
Drug: H2-water (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-water (300 mL per day)
Trial: 28709081
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care with contingency management incentives for treatment attendance (CM-Att; n=30)
Trial: 26183437
Drug: Travalert dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Travalert dosing aid
Trial: 26183437
Drug: Frequency of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frequency of Missed Dose self-report measures
Trial: 24853306
Drug: Medication possession
RxNorm normalized name: ZINC OXIDE 17.5 g in 100 g TOPICAL LIPSTICK [Lipshade SPF 30 Obsessed]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication possession ratio
Trial: 23918028
Drug: Warmed intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warmed intravenous infusion
Trial: 18793578
Drug: Remifentanil (dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (dosing details not specified)
Trial: 16414395
Drug: Pale sulfonated
RxNorm normalized name: pale dock pollen extract
DrugBank: Rumex altissimus pollen (DB10901)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pale sulfonated shale oil (PSSO) 10% applied daily for 20 weeks
Trial: 15282660
Drug: Recombinant platelet
RxNorm normalized name: Recombinant platelet-derived growth factor BB
DrugBank: Becaplermin (DB00102)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Recombinant platelet factor 4 (rPF4) at doses of 0.5, 1.0, 2.5, or 5.0 mg/kg
Trial: 9740864
Drug: Rilmenidine 1
RxNorm normalized name: rilmenidine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine 1 mg/d
Trial: 8376914
Drug: ridogrel 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ridogrel 300 mg b.i.d.
Trial: 8376914
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ridogrel 300 mg b.i.d. and ketanserin 20 mg t.i.d.
Trial: 8376914
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with ridogrel and ketanserin during 3-month follow-up
Trial: 22956204
Drug: Ropivacaine wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine wound infusion (0.5%)
Trial: 15660547
Drug: Soft music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft music (six 45‐minute sedative music tapes) for 3 weeks
Trial: 10735922
Drug: Furazolidone 200
RxNorm normalized name: furazolidone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furazolidone 200 mg b.d. (RABF)
Trial: 10735922
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg b.d. (RABM)
Trial: 8960592
Drug: 500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/day of oral ascorbic acid
Trial: 1305155
Drug: Root planing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Root planing in conjunction with citric acid treatment
Trial: 3895033
Drug: mesulergine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mesulergine (mean dosage, 27.4 mg/d)
Trial: 3895033
Drug: bromocriptine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromocriptine (mean dosage, 40.8 mg/d)
Trial: 24673474
Drug: Classic Antihistamines
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classic Antihistamines
Trial: 24673474
Drug: New-generation Antihistamines
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New-generation Antihistamines
Trial: 22925074
Drug: Flaxseed extract
RxNorm normalized name: flaxseed extract
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed extract (1 g/day, containing at least 100 mg of SDG)
Trial: 22925074
Drug: Flaxseed meal
RxNorm normalized name: FLAXSEED MEAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed meal (90 g/day, containing at least 270 mg of SDG)
Trial: 22925074
Drug: Collagen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen (1 g/day, placebo group)
Trial: 20116706
Drug: Single-day antibiotic
RxNorm normalized name: bacitracin
DrugBank: Bacitracin (DB00626)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-day antibiotic prophylaxis
Trial: 18589558
Drug: Tacrolimus 5
RxNorm normalized name: tacrolimus 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus 5 mg capsules under fasting conditions
Trial: 18589558
Drug: Tacrolimus 5
RxNorm normalized name: tacrolimus 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus 5 mg capsules under fed conditions
Trial: 8116134
Drug: Orchiectomy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orchiectomy plus estramustine phosphate (EMP), 2 x 280 mg/day
Trial: 8116134
Drug: Orchiectomy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orchiectomy plus flutamide, 3 x 250 mg/day
Trial: 3220007
Drug: sulbactam 250
RxNorm normalized name: sulbactam 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulbactam 250 mg plus ampicillin 500 mg intravenously
Trial: 3220007
Drug: sultamicillin equivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sultamicillin equivalent to sulbactam 294 mg plus ampicillin 440 mg orally
Trial: 3220007
Drug: clavulanic acid
RxNorm normalized name: Clavulanic acid
DrugBank: Clavulanic acid (DB00766)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: clavulanic acid 100 mg plus amoxycillin 500 mg intravenously
Trial: 3220007
Drug: clavulanic acid
RxNorm normalized name: Clavulanic acid
DrugBank: Clavulanic acid (DB00766)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: clavulanic acid 125 mg plus amoxycillin 500 mg orally
Trial: 31903588
Drug: Dexmedetomidine (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (loading dose of 0.6 μg/kg 10 min before induction followed by continuous infusion of 0.5 μg/kg/h until 1h before end of surgery)
Trial: 30315206
Drug: Daily PrEP
RxNorm normalized name: Zinc Oxide 238 mg in 1 mL / Titanium Dioxide 41 mg in 1 mL TOPICAL LOTION [bareMinerals Prep Step Mineral Shield Broad Spectrum SPF 50 Daily Prep]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily PrEP with TDF-FTC
Trial: 24529292
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (wet-granulation tablet)
Trial: 24529292
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (dry-granulation tablet)
Trial: 21737124
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) with 20 μg estrogen
Trial: 21737124
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) with 30 μg estrogen
Trial: 21737124
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) with 35 μg estrogen
Trial: 21737124
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) with 50 μg estrogen
Trial: 11507356
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg twice a day, amoxycillin 1 g twice a day, tinidazole 500 mg twice a day (FAT group; n = 60)
Trial: 11507356
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg twice a day, amoxycillin 1 g twice a day, tinidazole 500 mg twice a day (OAT group; n = 60)
Trial: 6233550
Drug: Blo-Bag with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blo-Bag with Duovent metered dose inhaler
Trial: 31436839
Drug: Nelfinavir mesylate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir mesylate, 625 mg, twice daily
Trial: 31436839
Drug: Nelfinavir mesylate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir mesylate, 1250 mg, twice daily
Trial: 20586515
Drug: Tapentadol ER
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol ER 100-250 mg twice daily
Trial: 20586515
Drug: Oxycodone CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone CR 20-50 mg twice daily
Trial: 10751029
Drug: Zafirlukast solution
RxNorm normalized name: Zafirlukast
DrugBank: Zafirlukast (DB00549)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zafirlukast solution (40 mg) administered orally
Trial: 10751029
Drug: Zafirlukast solution
RxNorm normalized name: Zafirlukast
DrugBank: Zafirlukast (DB00549)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zafirlukast solution (40 mg) administered via oroenteric tube into the colon
Trial: 10751029
Drug: Zafirlukast solution
RxNorm normalized name: Zafirlukast
DrugBank: Zafirlukast (DB00549)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zafirlukast solution (40 mg) administered into the distal ileum
Trial: 8925829
Drug: Enalapril (ENAL),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (ENAL), an angiotensin converting enzyme inhibitor (ACE-I), 5 mg acute administration
Trial: 23782429
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (300,000 IU cholecalciferol in oily solution administered seven days pre-operatively)
Trial: 21665114
Drug: Topical cetylated
RxNorm normalized name: cetyl dimethicone Topical Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cetylated fatty ester complex (CFEC) cream application plus physical therapy (CF‐PT)
Trial: 21665114
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream application plus physical therapy (PL‐PT)
Trial: 10638577
Drug: Slow-release 5-ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release 5-ASA suppositories (Pentasa 1 g/day)
Trial: 10638577
Drug: Conventional 5-ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional 5-ASA suppositories (Rowasa 0.5 g b.i.d.)
Trial: 26232779
Drug: 150 ml/dinner
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml/dinner dry red wine
Trial: 26232779
Drug: 150 ml/dinner
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml/dinner dry red wine (among fast ethanol metabolizers)
Trial: 24447498
Drug: Lower-dose tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lower-dose tranexamic acid regimen (loading dose of 10 mg/kg, maintenance dose of 2 mg/kg/h, pump prime dose of 40 mg)
Trial: 24447498
Drug: Higher-dose tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher-dose tranexamic acid regimen (loading dose of 30 mg/kg, maintenance dose of 16 mg/kg/h, pump prime dose of 2 mg/kg)
Trial: 20380656
Drug: Dutogliptin 400
RxNorm normalized name: Dutogliptin
DrugBank: Dutogliptin (DB11723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutogliptin 400 mg
Trial: 20380656
Drug: Dutogliptin 200
RxNorm normalized name: Dutogliptin
DrugBank: Dutogliptin (DB11723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutogliptin 200 mg
Trial: 16117574
Drug: Psychological therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological therapy (PRP trial)
Trial: 12577349
Drug: Integrated traditional
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated traditional Chinese and western medicine (TCM-WM) including cardiac diuretics, vasodilative agents, taurine, coenzyme Q10, antiarrhythmics, beta blockers, and Chinese herbal preparations such as Astragalus membranaceus and Shengmai injection.
Trial: 12577349
Drug: Conventional western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional western medicine alone (control group).
Trial: 9713095
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment (Group 1)
Trial: 9713095
Drug: Discontinuous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuous treatment (Group 2)
Trial: 2740841
Drug: Sucralfate in
RxNorm normalized name: Product containing sucralfate in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate in tablets
Trial: 2740841
Drug: Sucralfate in
RxNorm normalized name: Product containing sucralfate in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate in suspension
Trial: 31374049
Drug: Xiaoai Jiedu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaoai Jiedu Decoction mimetic agent
Trial: 25458464
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) treatment (2400 mg/day divided into two doses) for 4 weeks
Trial: 18239389
Drug: Candesartan (angiotensin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (angiotensin II receptor antagonist)
Trial: 16820564
Drug: AMI cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMI cell infusion
Trial: 16820564
Drug: OMI cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OMI cell infusion
Trial: 12752749
Drug: Sumatriptan (tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (tablet and nasal spray) and naratriptan (tablet)
Trial: 9531736
Drug: Transdermal ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal ketoprofen 30 mg over the proposed surgical area twice (Group 1)
Trial: 9531736
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch (Group 2)
Trial: 9531736
Drug: Transdermal ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal ketoprofen 30 mg over right thigh twice (Group 3)
Trial: 31752976
Drug: Empirical antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical antimicrobial therapy
Trial: 8196571
Drug: Early systemic
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early systemic antifungal treatment
Trial: 3065085
Drug: Tamoxifen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (30 mg/day) + bromocriptine (5 mg/day)
Trial: 30993313
Drug: Metformin XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin XL (2000 mg daily for 12 months)
Trial: 29979390
Drug: Fotemustine at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fotemustine at 120 mg/m biweekly
Trial: 29979390
Drug: Fotemustine at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fotemustine at 140 mg/m biweekly
Trial: 29979390
Drug: Standard weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard weekly schedule at 80 to 100 mg/m (not directly tested in this trial)
Trial: 27123229
Drug: Desmopressin 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin 120 micrograms daily for 2 months, then 60 micrograms daily for 2 months, then 60 micrograms every 2 days
Trial: 27123229
Drug: Oxybutynin 5
RxNorm normalized name: oxyBUTYnin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin 5 mg twice a day for 6 months
Trial: 17305893
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 6 hours later (n=225)
Trial: 17305893
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 36-48 hours later (n=225)
Trial: 17305893
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 6 hours later
Trial: 17305893
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms 36-48 hours later
Trial: 9864835
Drug: i.v. TNFR55-IgG1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. TNFR55-IgG1 0.01 mg/kg
Trial: 9864835
Drug: i.v. TNFR55-IgG1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. TNFR55-IgG1 0.05 mg/kg
Trial: 9864835
Drug: i.v. TNFR55-IgG1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. TNFR55-IgG1 0.1 mg/kg
Trial: 9864835
Drug: i.v. TNFR55-IgG1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. TNFR55-IgG1 0.5 mg/kg
Trial: 9864835
Drug: i.v. TNFR55-IgG1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. TNFR55-IgG1 20 mg biweekly
Trial: 9864835
Drug: i.v. TNFR55-IgG1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. TNFR55-IgG1 50 mg monthly after loading dose of 100 mg
Trial: 7890253
Drug: Ethanol (1
RxNorm normalized name: ALCOHOL 95 mL in 100 mL TOPICAL SOLUTION [95% Ethanol (190 Proof)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (1 ml/kg, 95% ethanol)
Trial: 2197536
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 300 mg of pentamidine every 28 days
Trial: 2197536
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of placebo (300 mg of Na isethionate) every 28 days
Trial: 343479
Drug: Extradural injection
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRADURAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extradural injection of 2 ml (80 mg) methyl prednisolone
Trial: 343479
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received 2 ml normal saline solution
Trial: 26340540
Drug: Zephyr® EBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zephyr® EBV treatment in upper lobe (n=45)
Trial: 26340540
Drug: Zephyr® EBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zephyr® EBV treatment in lower lobe (n=15)
Trial: 24042256
Drug: Aspirin (81-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81-100 mg daily)
Trial: 19848195
Drug: Qingxuan Tiaoya
RxNorm normalized name: SILICON DIOXIDE 14 g in 100 g / .ALPHA.-TOCOPHEROL ACETATE 0.1 g in 100 g / SODIUM PYROPHOSPHATE 0.5 g in 100 g DENTAL PASTE, DENTIFRICE [Mastikis Qingxin Care Mastic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingxuan Tiaoya Recipe (QXTYR) + perindopril tablet
Trial: 19848195
Drug: Simulator of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simulator of QXTYR + perindopril tablet
Trial: 17563125
Drug: Ebastine 10
RxNorm normalized name: ebastine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine 10 mg FDT